Efficacy of Escherichia coli Nissle 1917 for the Prevention of Recurrent Urinary Tract Infections in Women: A Preliminary Controlled Prospective Study
Clinics and Practice · 21.03.2026 · 16 (3) · 62
DOI: 10.3390/clinpract16030062 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinics and Practice, online erschienen am 21.03.2026. Verfasst von Filippo Murina und 3 weiteren Autor:innen. Beteiligte Einrichtung: Lower Genital Tract Disease Unit, V. Buzzi Hospital, University of the Study of Milan, 20154 Milan, Italy. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 17 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background/Objectives: More than 50% of adult women experience at least one urinary tract infection (UTI) during their lifetime, and approximately 25% develop recurrent UTIs (rUTIs), defined as ≥2 episodes within six months. Management of rUTI is challenging and often requires long-term, multimodal preventive strategies. Escherichia coli Nissle 1917 (EcN) is a non-pathogenic probiotic strain with demonstrated antagonistic activity against pathogenic enterobacteria. This study evaluated the efficacy and safety of EcN in preventing symptomatic recurrences in premenopausal women with rUTI.
Methods
In this prospective observational study, 40 premenopausal women with rUTI were enrolled. Twenty patients received EcN prophylaxis (twice daily for four weeks, followed by once daily for eight weeks), while 20 patients received no prophylaxis and served as controls. Patients were followed for six months (three months of treatment and three months post-treatment). The primary outcome was the frequency of symptomatic rUTI episodes during follow-up.
Results
Forty patients were analyzed (20 EcN; 20 controls). During the six-month observation period, 55% (11/20) of patients in the EcN group remained UTI-free compared with 35% (7/20) in the control group. Two patients (10%) in the EcN group experienced a single recurrence versus three (15%) in the control group. Recurrent episodes (≥2 UTIs) occurred in 35% (7/20) of EcN-treated patients compared with 50% (10/20) of controls. Overall, EcN prophylaxis was associated with a lower proportion of patients experiencing multiple recurrences.
Conclusions
Prophylaxis with E. coli Nissle 1917 was associated with a reduced rate of recurrent UTIs compared with no prophylaxis in premenopausal women, supporting its potential role as a non-antibiotic preventive strategy in rUTI management.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Lower Genital Tract Disease Unit, V. Buzzi Hospital, University of the Study of Milan, 20154 Milan, Italy.
- Clinical Obstetric and Gynecological, V. Buzzi Hospital, ASST-FBF-Sacco, University of the Study of Milan, 20154 Milan, Italy.
ORCID-Profile: Filippo Murina, Cecilia Fochesato, Valeria Savasi
Zitieren
APA
Murina, F., Fochesato, C., Recalcati, D., & Savasi, V. (2026). Efficacy of Escherichia coli Nissle 1917 for the Prevention of Recurrent Urinary Tract Infections in Women: A Preliminary Controlled Prospective Study. Clinics and Practice, 16(3), 62. https://doi.org/10.3390/clinpract16030062
Vancouver
Murina F, Fochesato C, Recalcati D, Savasi V. Efficacy of Escherichia coli Nissle 1917 for the Prevention of Recurrent Urinary Tract Infections in Women: A Preliminary Controlled Prospective Study. Clinics and Practice. 2026;16(3):62. doi:10.3390/clinpract16030062
BibTeX
@article{Murina2026,
author = {Murina, Filippo and Fochesato, Cecilia and Recalcati, Dario and Savasi, Valeria},
title = {Efficacy of Escherichia coli Nissle 1917 for the Prevention of Recurrent Urinary Tract Infections in Women: A Preliminary Controlled Prospective Study},
journal = {Clinics and Practice},
year = {2026},
volume = {16},
number = {3},
pages = {62},
doi = {10.3390/clinpract16030062}
}
EUVIMED